Are inflammatory factors related to retinal vessel caliber? The Beaver Dam Eye Study.

OBJECTIVE To examine the relationship of systemic markers of inflammation, endothelial dysfunction, and serum folate level to retinal vessel diameter. METHODS Cross-sectional analyses were completed for data from a random sample of 396 persons aged 50 to 86 years who underwent a baseline examination from 1988 to 1990. Standardized protocols for blood collection and measurement of markers were used. Diameters of arterioles and venules were measured from digitized photographs. Standard univariate and multivariate analyses were performed. RESULTS While controlling for age, smoking status, diabetes status, serum high-density lipoprotein cholesterol, and hematocrit, wider retinal venular diameters were associated with higher serum high-sensitivity C-reactive protein, interleukin 6, and amyloid A levels. While controlling for age, systolic and diastolic blood pressure, smoking, serum high-density lipoprotein cholesterol level, and gout, smaller arteriolar diameters were associated with higher serum amyloid A and lower serum albumin and folate levels but not high-sensitivity C-reactive protein or interleukin 6 levels. Levels of serum soluble intercellular adhesion molecule-1 and serum soluble E-selectin, markers of endothelial dysfunction, were not associated with retinal arteriolar or venular diameters. CONCLUSIONS These data show an association of inflammatory markers with larger retinal venular diameter, suggesting that retinal venular caliber may be a marker of systemic inflammation.

[1]  S. Joel,et al.  Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. , 1992, Journal of immunological methods.

[2]  L. Fratta,et al.  Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. , 2002, Diabetes.

[3]  Tien Yin Wong,et al.  Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study. , 2004, Investigative ophthalmology & visual science.

[4]  S. Humphries,et al.  Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. , 2000, Cytokine.

[5]  R. Klein,et al.  Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. , 1999, Ophthalmology.

[6]  A H Chester,et al.  Induction of nitric oxide synthase in human vascular smooth muscle: interactions between proinflammatory cytokines. , 1998, Cardiovascular research.

[7]  M. Wolzt,et al.  LPS-induced microvascular leukocytosis can be assessed by blue-field entoptic phenomenon. , 2004, American journal of physiology. Heart and circulatory physiology.

[8]  R. Klein,et al.  Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities Study. , 1999, American journal of epidemiology.

[9]  J. Singh,et al.  Hypertensive retinopathy. , 1983, Indian journal of ophthalmology.

[10]  R. Klein,et al.  Are retinal arteriolar abnormalities related to atherosclerosis?: The Atherosclerosis Risk in Communities Study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[11]  E. Frohlich,et al.  Arterial and venous compliance in obese and nonobese subjects. , 1996, The American journal of cardiology.

[12]  H. P. Wagener,et al.  Classification of Retinal Lesions in the Presence of Vascular Hypertension: Report submitted to the American Ophthalmological Society by the committee on Classification of Hypertensive Disease of the Retina. , 1947, Transactions of the American Ophthalmological Society.

[13]  G. Starkebaum,et al.  Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. , 1986, The Journal of clinical investigation.

[14]  R. Klein,et al.  Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study , 2001, The Lancet.

[15]  R. Klein,et al.  Prospective cohort study of retinal vessel diameters and risk of hypertension , 2004, BMJ : British Medical Journal.

[16]  The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group. , 1976, Preventive medicine.

[17]  Nader Rifai,et al.  Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment. , 2003, Clinical chemistry.

[18]  H. Morrison,et al.  Serum folate and risk of fatal coronary heart disease. , 1996, JAMA.

[19]  L. Fratta,et al.  Leptin induces direct vasodilation through distinct endothelial mechanisms. , 2000, Diabetes.

[20]  J. C. Parr,et al.  General caliber of the retinal arteries expressed as the equivalent width of the central retinal artery. , 1974, American journal of ophthalmology.

[21]  R. Kronmal,et al.  Retinal microvascular abnormalities and blood pressure in older people: the Cardiovascular Health Study , 2002, The British journal of ophthalmology.

[22]  M. Pepys,et al.  Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. , 1998, Clinical chemistry.

[23]  Tien Yin Wong,et al.  Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. , 2002, JAMA.

[24]  R. Klein,et al.  Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. , 2002, JAMA.

[25]  A. Hofman,et al.  Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. , 2004, Investigative ophthalmology & visual science.

[26]  Lipid hydroperoxide stimulates leukocyte-endothelium interaction in the retinal microcirculation. , 2002, Experimental eye research.

[27]  Tien Yin Wong,et al.  Retinal microvascular abnormalities and renal dysfunction: the atherosclerosis risk in communities study. , 2004, Journal of the American Society of Nephrology : JASN.

[28]  Kazushi Tamai,et al.  Lipid hydroperoxide stimulates leukocyte-endothelium interaction in the retinal microcirculation. , 2002, Experimental eye research.

[29]  R. Klein,et al.  Retinal vascular abnormalities in persons with type 1 diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVIII. , 2003, Ophthalmology.

[30]  R. Klein,et al.  Revised formulas for summarizing retinal vessel diameters , 2003, Current eye research.

[31]  R. Klein,et al.  The Beaver Dam Eye Study: visual acuity. , 1991, Ophthalmology.